Last updated: March 2026
Phenibut (β-Phenyl-GABA) is a GABA-B agonist and weak voltage-gated calcium channel blocker developed in the USSR for cosmonauts facing extreme stress. Effective anxiolytic and sleep aid — but carries severe addiction risk. Tolerance builds within days. Withdrawal can be life-threatening. Use requires strict frequency limits.
Phenibut is one of the most addiction-prone compounds covered on this site. Do not use daily. Do not use more than 1–2 times per week. Tolerance builds within 2–3 days of consecutive use. Physical dependence can develop within 1–2 weeks of daily dosing.
Phenibut crosses the blood-brain barrier more readily than GABA itself (due to the phenyl group) and acts primarily on GABA-B receptors. This makes its effects distinct from benzodiazepines, which act on GABA-A.
Phenibut is primarily a GABA-B agonist — the same receptor class as baclofen. GABA-B activation produces anxiolytic, sedative, and muscle-relaxant effects. Unlike benzodiazepines (GABA-A), GABA-B activation is associated with a different side effect profile and does not cause respiratory depression at therapeutic doses — but the addiction profile is still serious.
Phenibut also weakly blocks voltage-gated calcium channels (α2δ subunit) — the same mechanism as gabapentin and pregabalin. This contributes to its anxiolytic and analgesic effects. The dual mechanism (GABA-B + VGCC) likely explains why phenibut's effects feel distinct from pure GABA-B agonists.
Phenibut was developed in the 1960s at the Institute for Experimental Medicine in Leningrad. It was formulated for cosmonauts who needed anxiety reduction without impairment of cognitive function — a requirement that conventional sedatives failed to meet. It's still used medically in Russia and some post-Soviet states for anxiety, insomnia, and PTSD.
Tolerance to phenibut's effects (especially anxiolytic) develops extremely rapidly — often within 2–3 days of consecutive use. This is due to GABA receptor downregulation and reduced receptor sensitivity. Physical dependence follows. The withdrawal is the mirror image of its effects: anxiety, insomnia, agitation, and in severe cases, seizures and psychosis.
Phenibut has a long history of Russian clinical use. Western clinical data is limited but growing due to increasing use and reported dependence cases.
⚠️ Withdrawal Can Be Life-Threatening
If dependent on phenibut, do NOT stop cold turkey. Taper slowly (reduce dose by ~10% every 1–2 weeks) or seek medical supervision. Severe withdrawal may require hospitalization and benzodiazepine support similar to alcohol or GABA-B withdrawal protocols.
For those researching phenibut, these harm reduction tools are relevant.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational and harm reduction purposes only. Phenibut carries high addiction and dependence potential. Withdrawal can be life-threatening. It is not FDA approved. It is a scheduled/controlled substance in multiple countries. This is not medical advice. If you are experiencing phenibut dependence or withdrawal, seek immediate medical attention. Do not use phenibut without consulting a qualified healthcare provider.